Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.38 USD | +0.64% | -14.04% | -33.21% |
May. 08 | Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |